microRNA-497 slows esophageal cancer development and reverses chemotherapy resistance through its target QKI
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Author(s)
Related Research Unit(s)
Detail(s)
Original language | English |
---|---|
Pages (from-to) | 3791-3806 |
Journal / Publication | Aging |
Volume | 15 |
Issue number | 9 |
Online published | 11 May 2023 |
Publication status | Published - 15 May 2023 |
Link(s)
DOI | DOI |
---|---|
Attachment(s) | Documents
Publisher's Copyright Statement
|
Link to Scopus | https://www.scopus.com/record/display.uri?eid=2-s2.0-85159788857&origin=recordpage |
Permanent Link | https://scholars.cityu.edu.hk/en/publications/publication(76af9570-14e0-4baf-a9fd-02bbd772b5a9).html |
Abstract
Esophageal cancer (EC) is considered one of the most lethal cancers in human beings, and multiple miRNAs have been investigated to be involved in EC development by targeting their target genes. However, the function and related mechanism of miRNA-497 on EC tumorigenesis remain uncertain. This study first demonstrated that the expression levels of miR-497 in esophageal cancer specimens and cells were down-regulated. Forced expression of miR-497 inhibited cell proliferation, tube formation and migration in EC cells. To further investigate the potential molecular mechanism of miR-497 suppression in regulating EC, we found that miR-497 directly binds to the 3'-untranslational region of QKI, miR-497 overexpression suppressed QKI expression. We further found that overexpression of miR-497 enhanced the effect of chemotherapy in EC cell lines, and prevented the tumor growth of EC in vivo. Our findings indicated that miR-497 suppression increased QKI expression and therapeutic resistance of esophageal cancer, which is likely to be a biomarker of EC progression and potential therapeutic target.
© 2023 Xie et al.
© 2023 Xie et al.
Research Area(s)
- miRNA-497, QKI, esophageal cancer, chemotherapy resistance, tumor growth
Citation Format(s)
microRNA-497 slows esophageal cancer development and reverses chemotherapy resistance through its target QKI. / Xie, Yun-Xia; Zhou, Zhi-Hao; Liu, Shu-Wen et al.
In: Aging, Vol. 15, No. 9, 15.05.2023, p. 3791-3806.
In: Aging, Vol. 15, No. 9, 15.05.2023, p. 3791-3806.
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Download Statistics
No data available